Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure

被引:10
|
作者
Qiu, Liyuan [1 ,2 ]
Wang, Jian [3 ]
Wen, Xinyu [4 ]
Wang, Haibin [1 ,2 ]
Wang, Yan [1 ,2 ]
Lin, Qiuxia [1 ,2 ]
Du, Zhiyan [1 ,2 ]
Duan, Cuimi [1 ,2 ]
Wang, Chunren [3 ]
Wang, Changyong [1 ,2 ]
机构
[1] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing 100850, Peoples R China
[2] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100850, Peoples R China
[3] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China
来源
关键词
Co-microencapsulated; FHF; Hepatocyte; HUVEC; Transplantation; MARROW STEM-CELLS; LIVER-FAILURE; INTRASPLENIC TRANSPLANTATION; PORCINE HEPATOCYTES; ENDOTHELIAL-CELLS; IMPROVED SURVIVAL; RATS; ISLETS; COENCAPSULATION; HEPATECTOMY;
D O I
10.5301/ijao.5000092
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose: Microencapsulated hepatocytes might solve immunological rejection, broadening a new perspective for the treatment of fulminant hepatic failure (FHF). However, the transplantation of microcapsulated hepatocytes is limited by low cell viability. Nevertheless, the.co-microencapsulation of hepatocytes and human umbilical vein endothelial cells (HUVECs) may make the treatment of FHF more promising. Methods: We prepared the microcapsules using the high-voltage electrostatic droplet spray method, transplanted the empty microcapsules, isolated hepatocytes, microcapsulated hepatocytes, and co-microencapsulated hepatocytes and HUVEC intraperitoneally into rat models of FHF induced by D-aminogalactose (D-gal). After 1, 3, and 7 days, and 2, 3, and 4 weeks posttransplantation, we calculated the mortality and assessed alanine aminotransferase (ALT), aspartate aminotransferase (AST), and albumin (ALB) levels in the serum of the model; evaluated the integrality and recovery of microcapsules; and stained with hematoxylin and eosin (H&E) the recovered microcapsules as well as the liver of the FHF rats. Results: Hepatocyte-specific functions, including the levels of ALT, AST and ALB in the serum of the co-microencapsulation group, were significantly better than those in the other groups (p < 0.05) from 2 to 4 weeks after transplantation. Moreover, cotransplantation of the microencapsulated hepatocytes and HUVECs decreased the mortality rate of the FHF rats. The recovered microcapsules were intact, and recovery was up to 90%. H&E staining showed that the microencapsulated cells were still alive, and the liver tissues had started to recover after 4 weeks posttransplantation. Conclusion: The microcapsules have good biocompatibility and immunoprotection to protect the hepatocytes from immunological rejection. Cotransplantation of the microencapsulated hepatocytes and HUVECs could decrease mortality rates and improve liver function in FHF
引用
收藏
页码:458 / 465
页数:8
相关论文
共 50 条
  • [1] Transplantation of microencapsulated hepatocytes as therapy for fulminant liver failure
    Buhler, Leo
    XENOTRANSPLANTATION, 2007, 14 (05) : 427 - 428
  • [2] Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes
    Mai, G
    Huy, NT
    Morel, P
    Mei, J
    Andres, A
    Bosco, D
    Baertschiger, R
    Toso, C
    Berney, T
    Majno, P
    Mentha, G
    Trono, D
    Buhler, LH
    XENOTRANSPLANTATION, 2005, 12 (06) : 457 - 464
  • [3] Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes
    Mai, G
    Nguyen, TH
    Morel, PH
    Trono, D
    Buhler, L
    BRITISH JOURNAL OF SURGERY, 2004, 91 (07) : 902 - 903
  • [4] Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes
    Mai, G
    Huy, NT
    Morel, P
    Mei, J
    Bosco, D
    Berney, T
    Majno, P
    Mentha, G
    Trono, D
    Buhler, LH
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 527 - 529
  • [5] TRANSPLANTATION OF MICROENCAPSULATED ALLOGENIC HEPATOCYTES IN EXPERIMENTAL FULMINANT HEPATIC-FAILURE - INCREASED SURVIVAL WITHOUT IMMUNOSUPPRESSION
    DIXIT, V
    GORDON, VP
    PAPPAS, SC
    FISHER, MM
    HEPATOLOGY, 1988, 8 (05) : 1291 - 1291
  • [6] TRANSPLANTATION OF ISOLATED HEPATOCYTES FOR FULMINANT HEPATIC-FAILURE
    CUERVASMONS, V
    CIENFUEGOS, JA
    GOLITSIN, A
    EROLES, G
    MAGANTO, P
    CASTILLOOLIVARES, JL
    DEARANA, JMS
    EUROPEAN SURGICAL RESEARCH, 1982, 14 (02) : 172 - 172
  • [7] Improved Survival of Fulminant Liver Failure by Transplantation of Microencapsulated Cryopreserved Porcine Hepatocytes in Mice
    Mei, Jie
    Sgroi, Antonino
    Mai, Gang
    Baertschiger, Reto
    Gonelle-Gispert, Carmen
    Serre-Beinier, Veronique
    Morel, Philippe
    Buehler, Leo H.
    CELL TRANSPLANTATION, 2009, 18 (01) : 101 - 110
  • [8] Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes (vol 12, pg 457, 2005)
    Mai, G
    Nguyen, TH
    Morel, P
    Mei, J
    Andres, A
    Bosco, D
    Baertschiger, R
    Toso, C
    Berney, T
    Majno, P
    Mentha, G
    Trono, D
    Buhler, LH
    XENOTRANSPLANTATION, 2006, 13 (01) : 89 - 89
  • [9] ISOLATION OF HEPATOCYTES FOLLOWED BY TRANSPLANTATION INTO THE SPLEEN IN EXPERIMENTAL FULMINANT HEPATIC-FAILURE
    ARRANZ, JA
    TURRION, VS
    QUINTELA, AG
    MORA, NP
    TENDILLO, FJ
    CANTON, T
    NIETO, J
    CASTILLOOLIVARES, JL
    CUERVASMONS, V
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (03) : 1977 - 1977
  • [10] Liver transplantation for fulminant hepatic failure
    David H. Van Thiel
    John Brems
    Abdul Nadir
    Ramazan Idilman
    Alessandra Colantoni
    David Holt
    Steven Edelstein
    Journal of Gastroenterology, 2001, 36 : 1 - 4